Convergent Antibody Signatures in Human Dengue

• White blood cell DNA sequences reveal clonal B cell expansion in acute dengue patients
• Multiple dengue cases exhibit convergent dengue-specific antibody (CDR3) signatures
• Convergent CDR3s have diverse underlying nucleotide sequences
• Dengue-specific CDR3s have unique amino acid physicochemical profiles

SummaryDengue is the most prevalent mosquito-borne viral disease in humans, and the lack of early prognostics, vaccines, and therapeutics contributes to immense disease burden. To identify patterns that could be used for sequence-based monitoring of the antibody response to dengue, we examined antibody heavy-chain gene rearrangements in longitudinal peripheral blood samples from 60 dengue patients. Comparing signatures between acute dengue, postrecovery, and healthy samples, we found increased expansion of B cell clones in acute dengue patients, with higher overall clonality in secondary infection. Additionally, we observed consistent antibody sequence features in acute dengue in the highly variable major antigen-binding determinant, complementarity-determining region 3 (CDR3), with specific CDR3 sequences highly enriched in acute samples compared to postrecovery, healthy, or non-dengue samples. Dengue thus provides a striking example of a human viral infection where convergent immune signatures can be identified in multiple individuals. Such signatures could facilitate surveillance of immunological memory in communities.

Graphical AbstractFigure optionsDownload high-quality image (288 K)Download as PowerPoint slide